APR 13, 2020 12:56 PM PDT

Is fiber really associated with lower risk for breast cancer?

Up until now, there have been inconclusive results regarding the association between fiber consumption and the risk of breast cancer. In order to come to a final conclusion, researchers from the Harvard T.H. Chan School of Public Health conducted a systematic review and meta‐analysis of all relevant prospective studies on the topic published before August 2019. Their findings are published in the peer-reviewed journal of the American Cancer Society (ACS), Cancer.

Source: Pixabay

According to their analysis, high-fiber intake is in fact linked with a reduced incidence of breast cancer. The analysis considered data from 20 observational studies, from which they were able to identify that individuals with the highest consumption of fiber had an eight percent lower risk of breast cancer.

The researchers gather data from the MEDLINE and Excerpta Medica dataBASE (EMBASE) databases. From these databases, the authors identified 17 cohort studies, 2 nested case‐control studies, and 1 clinical trial study, with which they conducted their analysis.

Their analysis considered not only the total intake of fiber consumed but also the types of fiber. From this information, they found that soluble fiber, in particular, was associated with lower risks of breast cancer. Notedly, this finding was the same for women with premenopausal and postmenopausal breast cancer.

"Our study contributes to the evidence that lifestyle factors, such as modifiable dietary practices, may affect breast cancer risk," said Dr. Maryam Farvid, who led the research. "Our findings provide research evidence supporting the American Cancer Society dietary guidelines, emphasizing the importance of a diet rich in fiber, including fruits, vegetables, and whole grains."

Nevertheless, the researchers caution that the studies they analyzed were observational studies, meaning they only demonstrate the associations between consumption of fiber and breast cancer risk, not a direct cause. In order to establish direct cause, they say, a randomized clinical trial would be necessary.

Sources: Cancer, Science Daily

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
JUL 12, 2021
Cell & Molecular Biology
A Molecule From the Gut Microbiome May Fight Tumors
JUL 12, 2021
A Molecule From the Gut Microbiome May Fight Tumors
The more we learn abut the gut microbiome, the more it seems that the microorganisms in our gastrointestinal tracts can ...
SEP 09, 2021
Cancer
Can a Mole Fight Melanoma?
SEP 09, 2021
Can a Mole Fight Melanoma?
About 30% of melanoma cases arise from an existing nevus.  More commonly known as moles, Nevi are skin growths that ...
OCT 07, 2021
Cancer
Dual Threat: CAR T Cells Modified to Target Two Neuroblastoma Antigens
OCT 07, 2021
Dual Threat: CAR T Cells Modified to Target Two Neuroblastoma Antigens
Neuroblastoma is a cancer of immature nerve cells found in various areas, including the adrenal glands, neck, chest ...
OCT 10, 2021
Cell & Molecular Biology
DNA Can Reveal Treatments for Lung Cancer in 'Never-Smoked' Patients
OCT 10, 2021
DNA Can Reveal Treatments for Lung Cancer in 'Never-Smoked' Patients
There is a well-known causal connection between smoking and lung cancer, and most research on lung cancer has been focus ...
NOV 04, 2021
Cancer
Giving the Immune System a Kickstart to Improve Immunotherapy Efficacy
NOV 04, 2021
Giving the Immune System a Kickstart to Improve Immunotherapy Efficacy
Despite the incremental success immune checkpoint inhibitors (ICI) have attributed to the cancer treatment landscape rec ...
NOV 09, 2021
Immunology
Wikipedia, but Make It Immune Cells
NOV 09, 2021
Wikipedia, but Make It Immune Cells
Scientists have established the first searchable database of complex immune data, providing the foundations for a new er ...
Loading Comments...